Trial Profile
Clinical study of efficacy and safety of flumatinib combined with autologous hematopoietic stem cell transplantation in the treatment of Ph+ acute lymphoblastic leukemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2020
Price :
$35
*
At a glance
- Drugs Fostamatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 31 Jul 2020 New trial record